Note: Ingredients listed on restricted chemical lists
EC/CAS
200-098-7/51-43-4
Name of the chemical
Epinephrine (INN)
Concentration
1.0
EC/CAS
231-548-0/7631-90-5
Name of the chemical
Sodium hydrogensulphite; Sodium bisulphite
Concentration
*
EC/CAS
200-317-6/57-15-8
Name of the chemical
Chlorobutanol
Concentration
*
General Information
Revision date
2010-03-15
Product name
Epinephrine Injection
Chemical name
Not determined
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Appearance: Clear, colorless liquid
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term: May be absorbed through the skin and cause systemic effects. May be absorbed through mucous membranes and cause systemic effects. Known Clinical Effects: Adverse effects associated with therapeutic use include increased heart rate (tachycardia), palpitations, sweating, nausea, vomiting, difficulty breathing, dizziness, weakness, headache, anxiety, nervousness. EU Indication of danger: Not classified Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
